Techniques that cause multipotent adult mesenchymal stem cells (MSCs) to differentiate ... activities in the OA joint. Targeted gene therapy might further enhance these activities of MSCs.

This is especially problematic in cases of blocked blood vessels, which can repeatedly starve large areas of the heart of ...

The gene therapy Casgevy, which will now be offered to some patients in England, could help people live disease-free, experts ...

Beyond gene therapy, another issue of much debate relates to the use of stem cells. These cells can be divided into two broad classes: embryonic and adult. Both classes are currently being ...

In MS, immune system cells mistakenly attack myelin. With stem cell treatment, doctors use chemotherapy to destroy these existing immune cells. Then, they introduce the new stem cells, which are ...

In partnership with the National Institute of Allergy and Infectious Diseases, we committed nearly $4 million over five years to co-fund a major study of mesenchymal (adult) stromal cells as a new ...

The Global Stem Cell Therapy For Diabetes Related Conditions market industry is primarily driven by the continuous advancements in technology.

Now a new stem cell treatment is being evaluated in a Phase 3 trial in the United States which, if successful, could provide patients with an alternative to surgery. Orthopedic surgeon Dr.

Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® ...

which use the patient’s stem cells in the treatment, and allogeneic therapies, which are not personalized for a single patient. “We’ve seen big breakthroughs where these treatments have ...